Literature DB >> 8035927

Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases.

B Pillon1, B Deweer, A Michon, C Malapani, Y Agid, B Dubois.   

Abstract

To test the hypothesis that memory disorders of subcortico-frontal dementia result mainly from inefficiency of retrieval processes of stored information, we compared verbal learning in 15 patients with progressive supranuclear palsy, prototypical of "subcortical dementia," in free (California Verbal Learning Test) and controlled (Grober and Buschke's Test) encoding situations, with that of 19 controls, matched for age and level of education. The progressive supranuclear palsy patients showed memory deficits characterized by impaired immediate memory span, disturbed learning and consistency of recall, and abnormal number of false alarms at recognition, which were dramatically alleviated by controlled encoding associated with cued recall, using the same semantic cues. This memory profile was markedly different from that of patients with senile dementia of the Alzheimer type (n = 15), characterized by more rapid forgetting and less improvement in the controlled situation. Instead, it was similar to the memory pattern of patients with Parkinson's (n = 15) and Huntington's (n = 15) diseases. These results show a similar profile of memory disturbance in disorders involving damage to the striatofrontal system and suggest that the cortical and hippocampal lesions of PSP patients are insufficiently severe to interfere with the specific memory profile characteristic of the disease.

Entities:  

Mesh:

Year:  1994        PMID: 8035927     DOI: 10.1212/wnl.44.7.1264

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Normative data for a battery of free recall, cued recall and recognition tests in the elderly Italian population.

Authors:  Emanuele Coluccia; Nadia Gamboz; Maria A Brandimonte
Journal:  Neurol Sci       Date:  2011-09-15       Impact factor: 3.307

Review 2.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 3.  Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.

Authors:  R van Reekum; M Simard; K Farcnik
Journal:  Can Fam Physician       Date:  1999-04       Impact factor: 3.275

4.  Regional lobar atrophy predicts memory impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov; Dominic A Carone; Bianca Weinstock-Guttman; Jeff Gaines; Cosimo Maggiore; Jitendra Sharma; Maria-Antonietta Tomassi; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

5.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

Authors:  T Esmonde; E Giles; M Gibson; J R Hodges
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

Review 6.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

7.  Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.

Authors:  B Pillon; N Gouider-Khouja; B Deweer; M Vidailhet; C Malapani; B Dubois; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

Review 8.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

9.  Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia.

Authors:  J Vincent Filoteo; David P Salmon; Dawn M Schiehser; Amy E Kane; Joanne M Hamilton; Laurie M Rilling; John A Lucas; Vanessa Zizak; Douglas R Galasko
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

10.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Benjamin Mast; Kevin Duff; Tanis J Ferman; Irene Litvan
Journal:  Arch Clin Neuropsychol       Date:  2012-11-04       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.